27 results
20-F/A
2021 FY
SLGL
Sol-Gel Technologies Ltd
7 Apr 22
Annual report (foreign) (amended)
4:06pm
some form of acne. Acne patients suffer from the appearance of lesions on areas of the body with a large concentration of oil glands, such as the face
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
12 Nov 21
Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
12:00am
of oil glands, such as the face, chest, neck and back. These lesions can be inflamed (papules, pustules, nodules) or non-inflamed (comedones). Acne
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
4 Aug 21
Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights
7:16am
patients suffer from the appearance of lesions on areas of the body with a large concentration of oil glands, such as the face, chest, neck and back
6-K
EX-99.1
j42nsglw5kwlinf i4
27 Jul 21
TWYNEO®, a once-daily cream treatment for acne vulgaris, is the first FDA‑approved fixed‑dose combination of tretinoin and benzoyl peroxide
10:39am
6-K
EX-99.1
aqdu i0vb
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
sh5c q9hyyiduk
13 May 21
Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update
7:16am
6-K
EX-99.1
zkdic
4 Mar 21
Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update
7:37am
6-K
EX-99.1
fq0cn0n iioco8h
7 Dec 20
Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug
7:41am
6-K
EX-99.1
33ee0kg edyx4rk
12 Nov 20
Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
9:07am
6-K
EX-99.1
texk53
6 Aug 20
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update
10:37am
6-K
EX-99.1
5duo hv2cgclstgahep
14 May 20
Sol-Gel Technologies Reports First Quarter 2020 Financial Results and Corporate Update
11:14am
6-K
EX-99.1
v6ld6lb3
24 Mar 20
Sol-Gel Technologies Reports Full Year 2019 Financial Results and Corporate Update
4:38pm
6-K
EX-99.1
y71 rcumvdoaq
5 Feb 20
Current report (foreign)
3:38pm
6-K
EX-99.1
iu1qweh
8 Jan 20
Sol-Gel Hosts Investor Call to Discuss Positive Results from Twyneo® Phase 3 Program in Acne Vulgaris
6:02am
6-K
EX-99.1
hjn4zn2 5468nlq5esh
30 Dec 19
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of
7:40am
6-K
EX-99.1
g52gs
26 Dec 19
Current report (foreign)
6:03am